CD14 and diabetes mellitus: For example, circulating CD34(+) and CD14(+) PBMCs express and secret the antiomiR-126, and an alteration of angiomiR-126 expression in CD34(+) PBMCs in diabetes provides a novel pathway causing impaired proangiogenic effects [49].